Brand Name :
Combigan
Synonyms :
brimonidine and timolol
Class :
Antiglaucoma
Dosage Forms & Strengths
brimonidine/timolol
ophthalmic solution
(2mg/5mg)/ml (0.2%/0.5%)
Indicated for Elevated intraocular pressure with Glaucoma:
Instil 1 drop in each affected eye twice a day,12 hours apart approximately
Dosage Forms & Strengths
brimonidine/timolol
ophthalmic solution
(2mg/5mg)/ml (0.2%/0.5%)
Indicated for Elevated IOP in Patients with Glaucoma :
>2 years: Instil 1 drop in each affected eye twice a day,12 hours apart approximately
<2 years: Contraindicated
Refer adult dosing
may increase the AV-blocking effect of beta blockers
may increase the AV-blocking effect of beta blockers
may increase the AV-blocking effect of beta blockers
may increase the AV-blocking effect of beta blockers
may increase the AV-blocking effect of beta blockers
may increase the AV blocking effect of alpha2 agonists
may increase the AV blocking effect of alpha2 agonists
may increase the AV blocking effect of alpha2 agonists
may increase the AV blocking effect of alpha2 agonists
may increase the AV blocking effect of alpha2 agonists
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of bradycardic agents
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of beta blockers
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may decrease the bronchodilatory effect
may decrease the bronchodilatory effect
may decrease the bronchodilatory effect
may decrease the bronchodilatory effect
may decrease the bronchodilatory effect
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the CNS depressant effect of CNS depressants
may increase the bradycardic effect of beta blockers
may increase the bradycardic effect of beta blockers
may increase the hypoglycaemic effect of beta blockers
may increase the hypoglycaemic effect of beta blockers
may increase the hypoglycaemic effect of beta blockers
may increase the hypoglycaemic effect of beta blockers
may increase the hypoglycaemic effect of beta blockers
may increase the hypotensive effect of beta blockers
may increase the hypotensive effect of beta blockers
may increase the hypotensive effect of beta blockers
may increase the hypotensive effect of beta blockers
may increase the hypotensive effect of beta blockers
may decrease the therapeutic effect of beta blockers
may decrease the therapeutic effect of beta blockers
may decrease the therapeutic effect of beta blockers
may decrease the therapeutic effect of beta blockers
may decrease the therapeutic effect of beta blockers
may increase the CNS depressant effect of CNS depressants
Mechanism of action
brimonidine is an alpha-2 adrenergic receptor agonist. It works by decreasing the production of aqueous humor in the eye and increasing the outflow of fluid from the eye, which helps to lower IOP. The drug also has a mild vasoconstrictive effect that helps to reduce the size of blood vessels in the eye, further decreasing IOP
timolol is a non-selective beta-blocker that works by reducing the production of aqueous humor in the eye and decreasing the inflow of blood into the eye. This also helps to lower IOP
Spectrum
Both brimonidine and timolol have a broad spectrum of activity, effectively treating a wide range of patients with elevated IOP. However, they may not be effective in all patients, and the IOP-lowering effect can vary from person to person. Additionally, both drugs can cause side effects, such as burning or stinging of the eyes, redness of the eyes, dry mouth, and drowsiness
Frequency defined:
5-15%
conjunctival folliculosis
eye pruritis
stinging
allergic conjunctivitis
conjunctival hyperemia
ocular burning
1-5%
blepharitis
depression
eye discharge
eye irritation
eyelid edema
foreign body sensation
hypertension
somnolence
visual disturbance
asthenia
corneal erosion
epiphora
eye dryness
eye pain
eyelid erythema
eyelid pruritis
headache
oral dryness
Contraindications
Contraindications of brimonidine:
Contraindications of timolol:
Caution
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology
brimonidine and timolol are medications used in the treatment of Glaucoma and other conditions that increase intraocular pressure. brimonidine is an alpha-2 adrenergic agonist that works by reducing aqueous humor production and increasing uveoscleral outflow, which helps to lower intraocular pressure. timolol is a non-selective beta-adrenergic blocker that works by reducing aqueous humor production and improving outflow, which helps to lower intraocular pressure
Pharmacodynamics
Activation of alpha-2 adrenergic receptors by brimonidine led to decreased aqueous humor production and increased uveoscleral outflow, which helps to lower intraocular pressure. brimonidine also has vasoconstrictive effects, which help to reduce the risk of hypotension (low blood pressure) and improve blood flow to the optic nerve
Blocking beta-adrenergic receptors by timolol leads to decreased aqueous humor production and improved outflow, which helps to lower intraocular pressure. timolol also has vasodilatory effects, which help to reduce the risk of adverse cardiovascular effects
Pharmacokinetics
Absorption
brimonidine is rapidly absorbed after topical ocular administration, reaching peak concentrations within 2-4 hours. timolol is rapidly absorbed after oral or topical ocular administration, with peak concentrations reached within 2-4 hours.
Distribution
brimonidine is widely distributed in the body, but only small amounts are found in the bloodstream. timolol is widely distributed in the body, with high concentrations found in the heart and lungs.
Metabolism
brimonidine is metabolized in the liver, primarily by cytochrome P450 3A4 (CYP3A4) enzymes. timolol is metabolized in the liver, primarily by cytochrome P450 2D6 (CYP2D6) enzymes.
Elimination/Excretion
brimonidine is excreted primarily in the urine, with a half-life of approximately 2 hours. timolol is excreted primarily in the urine, with a half-life of approximately 6-10 hours
Administration
It is administered topically to the eye. The eye drops are instilled in the affected eye(s) one to two times a day, as directed by your doctor. The topical gel is applied to the affected eye(s) once daily, as directed by your doctor
Patient information leaflet
Generic Name: brimonidine and timolol
Why do we use brimonidine and timolol?
Ophthalmic brimonidine and timolol is used to treat ocular hypertension or open-angle Glaucoma (high pressure inside the eye)